{"DataElement":{"publicId":"2917527","version":"1","preferredName":"Core Biopsy Prostate Gland Malignant Neoplasm Performed Percentage Value","preferredDefinition":"the percentage value related to the removal of a tissue sample of abnormal and uncontrolled cell growth located in the prostate gland, a gland of the male reproductive system just below the bladder, using a needle with a relatively large diameter, for microscopic examination and determined to be malignant, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"COR_PRS_MAL_PER_PV","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2760125","version":"1","preferredName":"Core Biopsy Prostate Gland Malignant Neoplasm Performed","preferredDefinition":"information related to the removal of a tissue sample of abnormal and uncontrolled cell growth located in the prostate gland, a gland of the male reproductive system just below the bladder, using a needle with a relatively large diameter, for microscopic examination and determined to be malignant, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"COREBX_PRST_MAL_PERF","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2483548","version":"1","preferredName":"Core Biopsy","preferredDefinition":"The removal of a tissue sample with a needle for examination under a microscope.","longName":"C15680","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Core Biopsy","conceptCode":"C15680","definition":"The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"148B6A47-AA7F-5290-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-24","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-24","modifiedBy":"ONEDATA","dateModified":"2006-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2760123","version":"1","preferredName":"Prostate Malignant Neoplasm Performed","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Performed; carried out.","longName":"C12410:C9305:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF4D371-01C8-3A7E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-18","modifiedBy":"ONEDATA","dateModified":"2008-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF4D371-01D9-3A7E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181282","version":"1","preferredName":"Test Percentage Value","preferredDefinition":"information related to the percentage value for a specific test.","longName":"TST_PTG_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","format":"999.9","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3C9A269-A842-2E72-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-20","modifiedBy":"PWEST","dateModified":"2006-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171065","version":"1","longName":"RTOG-0924","context":"NRG"},{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"}]}],"AlternateNames":[{"name":"COR_PRS_MAL_PER_PV","type":"USED_BY","context":"NRG"},{"name":"MI_MIORRES_PERC_POSITIVECORES","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Total % of positive core biop","type":"Preferred Question Text","description":"Total % of positive core biopsies taken","url":null,"context":"CTEP"},{"name":"CRF Text 1","type":"Alternate Question Text","description":"Percent of submitted positive core biopsies of all sextants","url":null,"context":"NRG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Percentage of positive cores at biopsy","url":null,"context":"CCTG"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6E4D712F-6A43-4CB1-E040-BB89AD430AF9","latestVersionIndicator":"Yes","beginDate":"2009-07-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-09","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeDescription":null,"administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"}}